Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study

Figure 1

Longitudinal evaluation of candidate cytokine concentrations categorized by incident neuropathic symptom status. Incident neuropathic symptoms developed within 12 weeks of starting cART. The control group refers to the symptom-free nested control group paired for previously identified risk factors. *refers to within-group differences from baseline, p < 0.05. # refers to between-group differences from baseline levels, p < 0.05. Horizontal bars indicate median values with interquartile ranges. Baseline refers to pre-cART levels. Abbreviations: IL, interleukin; TNFα, tumour necrosis factor-α.

Back to article page